Literature DB >> 24360534

Sleep disorders in multiple sclerosis and their relationship to fatigue.

Christian Veauthier1, Friedemann Paul2.   

Abstract

Treatment of multiple sclerosis (MS)-related fatigue is still a challenging task, given that no proven therapies exist and its mechanisms are not known. Our review highlights the relationship between MS-related fatigue and sleep disorders (SD). Although many studies suggest a higher overall prevalence of SD in MS, there are no valid and robust data to confirm this hypothesis until now except for restless legs syndrome (RLS): the prevalence of RLS in MS patients-especially in those with severe pyramidal and sensory disability-seems to be four times higher than in controls subjects. RLS is sometimes difficult to distinguish from spasticity and in case of doubt, probatory dopaminergic therapy or polysomnographic (PSG) investigations may be helpful. Nocturia may impact MS-related fatigue and should be considered. The treatment of underlying SD led to an improvement of MS-related fatigue. From a scientific point of view, SD should be examined in all studies investigating MS-related fatigue and be considered as a relevant confounder.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fatigue Severity Scale; Insomnia; Modified Fatigue Impact Scale; Multiple sclerosis related fatigue; Nocturia; Periodic limb movement disorder; Restless legs syndrome; Sleep-related breathing disorders

Mesh:

Year:  2013        PMID: 24360534     DOI: 10.1016/j.sleep.2013.08.791

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  32 in total

1.  Nocturia in Patients With Multiple Sclerosis.

Authors:  Benoit Peyronnet; Lauren B Krupp; W Stuart Reynolds; Xavier Gamé; Gérard Amarenco; Jean-Nicolas Cornu; Lana Zhovtis Ryerson; Carrie Lyn Sammarco; Jonathan E Howard; Robert W Charlson; Roger R Dmochowski; Benjamin M Brucker
Journal:  Rev Urol       Date:  2019

2.  Headache in the course of multiple sclerosis: a prospective study.

Authors:  Marcel Gebhardt; Peter Kropp; Frank Hoffmann; Uwe K Zettl
Journal:  J Neural Transm (Vienna)       Date:  2018-11-30       Impact factor: 3.575

Review 3.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

4.  Hypoxemia, Sleep Disturbances, and Depression Correlated with Fatigue in Neuromyelitis Optica Spectrum Disorder.

Authors:  Jing Pan; Peng Zhao; Hao Cai; Lei Su; Kristofer Wood; Fu-Dong Shi; Ying Fu
Journal:  CNS Neurosci Ther       Date:  2015-06-01       Impact factor: 5.243

5.  Central sleep apnea in multiple sclerosis: a pilot study.

Authors:  Michael Lin; Arun V Krishnan; Danny J Eckert
Journal:  Sleep Breath       Date:  2016-12-14       Impact factor: 2.816

Review 6.  Relationship between perceived fatigue and performance fatigability in people with multiple sclerosis: A systematic review and meta-analysis.

Authors:  Bryan D Loy; Ruby L Taylor; Brett W Fling; Fay B Horak
Journal:  J Psychosom Res       Date:  2017-06-27       Impact factor: 3.006

Review 7.  Managing Disability in Progressive Multiple Sclerosis.

Authors:  Divyanshu Dubey; Peter Sguigna; Olaf Stüve
Journal:  Curr Treat Options Neurol       Date:  2016-06       Impact factor: 3.598

Review 8.  Sleep Abnormalities in Multiple Sclerosis.

Authors:  Giorgos K Sakkas; Christoforos D Giannaki; Christina Karatzaferi; Mauro Manconi
Journal:  Curr Treat Options Neurol       Date:  2019-01-31       Impact factor: 3.598

9.  Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.

Authors:  Montserrat González-Platas; Javier González-Platas; Moises Bermúdez-Hernández; Maria Yaiza Pérez-Martín; Cristina Croissier-Elías; Pedro Javier Pérez-Lorensu
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

Review 10.  [Therapy of fatigue in multiple sclerosis : A treatment algorithm].

Authors:  C Veauthier; F Paul
Journal:  Nervenarzt       Date:  2016-12       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.